Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa

BACKGROUND: The efficacy of BCG may be enhanced by heterologous vaccination strategies that boost the BCG-primed immune response. One leading booster vaccine, MVA85A, has shown promising safety and immunogenicity in UK human trials. We investigated the safety and immunogenicity of MVA85A in mycobact...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hawkridge, Tony, Scriba, Thomas J., Gelderbloem, Sebastian, Smit, Erica, Tameris, Michele, Moyo, Sizulu, Lang, Trudie, Veldsman, Ashley, Hatherill, Mark, van der Merwe, Linda, Fletcher, Helen A, Mahomed, Hassan, Hill, Adrian V.S., Hanekom, Willem A., Hussey, Gregory D., McShane, Helen
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2822902/
https://ncbi.nlm.nih.gov/pubmed/18582195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/590185
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados